Navigation Links
Oncologists recognized by ESMO for outstanding contributions to cancer research and treatment
Date:9/19/2011

The European Society for Medical Oncology (ESMO) has honored three of Europe's leading medical oncologists with prestigious awards recognizing their achievements in clinical care and research.

"The eminent oncologists we are celebrating with these awards have each made enormous contributions to the care of patients with cancer," said Prof David Kerr, ESMO President. "We congratulate them and thank them for their unstinting efforts on behalf of others."

The 2011 ESMO Award has been granted to Prof Johann de Bono of The Institute of Cancer Research and The Royal Marsden's Hospital in the UK, for his outstanding contributions in translational and clinical research, innovative treatment, education and development of international guidelines for prostate cancer management.

"Prof de Bono has undertaken exceptional work in the development of a number of new innovative compounds for several new indications in oncology and has made important contributions to the development of new drugs in prostate cancer, particularly through excellence in translational research and study design," said Dr Josep Tabernero, Chair of the ESMO Fellowship and Award Committee.

The ESMO Award is conferred on an ESMO member who has made an outstanding contribution to the development of oncology in Europe and who recognizes the importance of promoting oncology as a specialty within the international community.

"This award is a great encouragement and will spur me on to continue to serve cancer patients," Prof de Bono said. "Drug development in oncology has made substantial strides forward over the last decade. While much still needs to be done, we can now be confident that much will be accomplished in the years ahead."

The Hamilton Fairley Award for 2011 has been awarded to Prof Rafael Rosell of the Catalan Institute of Oncology in Badalona, Spain. Prof Rosell is a leading figure in the field of lung cancer, who established a productive group of clinical and laboratory investigators in the Medical Oncology Department at Hospital Trias i Pujol, which has become one of the leading centers in lung cancer management.

"Prof Rosell's contributions range from tumor biology and prognostic and treatment-predictive markers, to clinical trials involving chemotherapy and targeted agents with careful dedication to personalized medicine," said Dr Tabernero.

The Hamilton Fairley Award commemorates one of the founding fathers of Medical Oncology in Europe and is presented to candidates who are internationally recognized for lifetime achievements in science and clinical/laboratory research.

"Nowadays, clinical achievements are basically propelled by translational research and therefore this award is a recognition of a multidisciplinary effort," Prof Rosell said. "It is a great honor for me to receive this award, but more importantly, I believe that the award is a recognition of the collective group of clinical and laboratory investigators, as well as statisticians and other key persons involved."

The ESMO Lifetime Achievement Award in 2011 goes to Prof Hans Jrg Senn of the Tumor and Breast Centre ZeTuP, in St Gallen, Switzerland.

"Prof Senn is being recognized for his work in organizing educational activities, which set the standards of care in breast cancer, mainly in relation to adjuvant treatment, as well as bringing prevention strategies to Medical Oncologists in Europe," said Prof Franco Cavalli, Chair of the ESMO Lifetime Achievement Award Committee. "His outstanding efforts through the organization of Consensus Conferences among breast cancer experts focused attention on addressing subtle questions in the adjuvant treatment of breast cancer, which presented a dilemma for practicing physicians."


'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert  

Related biology news :

1. Dana-Farber oncologists present at ASCO GU -- predict prostate cancer survival using Source MDx test
2. UAB oncologists: HPV vaccine protects from cancer recurrence
3. UF oncologists fight leukemia with two-pronged therapy, clinical trials planned
4. Value of satellites recognized for conserving wetlands
5. Pollution at home lurks unrecognized, instead attributed to large-scale environmental disasters
6. Household exposure to toxic chemicals lurks unrecognized, researchers find
7. 13 UCR faculty members recognized by American Association for the Advancement of Science
8. Federal scientists recognized for contributions to knowledge of bird ecology and habitat
9. Biomedical engineering student recognized as IEEEs New Face of Engineering
10. Heinz Maier-Leibnitz Prizes 2009: Six young researchers recognized for outstanding achievements
11. UC Riverside entomologist recognized for research in citrus entomology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Oncologists recognized by ESMO for outstanding contributions to cancer research and treatment
(Date:6/20/2016)... DALLAS , June 20, 2016 ... criminal justice technology solutions for public safety, investigation, ... by the prisons involved, it has secured the ... Corrections (DOC) facilities for Managed Access Systems (MAS) ... (4) additional facilities to be installed by October, ...
(Date:6/9/2016)... , June 9, 2016 ... deploy Teleste,s video security solution to ensure the safety of ... during the major tournament Teleste, an ... systems and services, announced today that its video security solution ... to back up public safety across the country. The ...
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or ... its major shareholders, Clean Technology Fund I, LP and ... based venture capital funds which together hold ... a fully diluted, as converted basis), that they have ... entire equity holdings in Biorem to TUS Holdings Co. ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. Hoffmann, ... faculty of the University of North Carolina Kenan-Flagler Business School effective ... at UNC Kenan-Flagler, with a focus on the school’s international efforts, leading classes ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of ... higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... of the cuvette holder. , FireflySci has developed several Agilent flow cell product ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology: